WHO ICTRP trial
The effects of clomiphen citrate versus letrozole in treatment of infertility
IRCT2015062422900N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT2015062422900N1 |
|---|---|
| Public title | The effects of clomiphen citrate versus letrozole in treatment of infertility |
| Scientific title | Clomiphen citrate versus letrozole with gonadotropins in intrauterine insemination cycles: A prospective randomized trial |
| Primary sponsor | Research Faculty of Mashhad University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | Ovulation induction. Female infertility associated with anovulation;Female infertility associated with anovulation |
| Interventions | Intervention 1: In the letrozole group, letrozole 2.5 mg BID was given for 5 days from day 3 of their menstrual cycle. In addition, all the patients received a daily intramuscular HMG. The dosage was 75 IU starting on day 6 of menstrual… |
| Registration date | Apr 22, 2016 |
| Target size | 180 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: